Biogen Inc (BIIB)
Operating profit margin
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 1,877,500 | 2,490,300 | 2,097,300 | 2,889,100 | 2,791,400 |
| Revenue | US$ in thousands | 9,810,600 | 9,675,900 | 9,835,600 | 10,173,400 | 10,981,700 |
| Operating profit margin | 19.14% | 25.74% | 21.32% | 28.40% | 25.42% |
December 31, 2025 calculation
Operating profit margin = Operating income ÷ Revenue
= $1,877,500K ÷ $9,810,600K
= 19.14%
Peer comparison
Dec 31, 2025
Company name
Symbol
Operating profit margin
Biogen Inc
BIIB
19.14%
AbbVie Inc
ABBV
34.69%
Amgen Inc
AMGN
40.52%
Bristol-Myers Squibb Company
BMY
20.00%
Johnson & Johnson
JNJ
24.94%